Melissa D. Pinto

Melissa D. Pinto

Auto-generated profile, based on publicly available information

Melissa D. Pinto

Sue & Bill Gross School of Nursing University of California Irvine Irvine California USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2022 in Clinical Nursing Research
Verified
Journal Article
Closed access
YHYong Huang
Yong Huang
MPMelissa D. Pinto
Melissa D. Pinto
JBJessica L. Borelli
Jessica L. Borelli
MMMilad Asgari Mehrabadi
Milad Asgari Mehrabadi
HAHeather L. Abrahim
Heather L. Abrahim
CDCharles A. Downs
Charles A. Downs
Post-acute sequelae of SARS-CoV-2 (PASC) is defined as persistent symptoms after apparent recovery from acute COVID-19 infection, also known as COVID-19 long-haul. We performed a retrospective review of electronic health records (EHR) from the University of California COvid Research Data Set (UC CORDS), a de-identified EHR of PCR-confirmed SARS-CoV-2-positive patients in California. The purposes were to (1) describe the prevalence of PASC, (2) describe COVID-19 symptoms and symptom clusters, and (3) identify risk factors for PASC. Data were subjected to non-negative matrix factorization to identify symptom clusters, and a predictive model of PASC was developed. PASC prevalence was 11% (277/2,153), and of these patients, 66% (183/277) were considered asymptomatic at days 0–30. Five PASC symptom clusters emerged and specific symptoms at days 0–30 were associated with PASC. Women were more likely than men to develop PASC, with all age groups and ethnicities represented. PASC is a public health priority.

13 December 2019 in Social Theory & Health
Verified
Journal Article
Open access
PDF file
MAMarcia J Ash
Marcia J Ash
THTimothy Harrison
Timothy Harrison
MPMelissa Pinto
Melissa Pinto
RDRalph DiClemente
Ralph DiClemente
LNLobsang Tenzin Negi
Lobsang Tenzin Negi
Across cultures and belief systems, compassion is widely considered to be beneficial for the development of personal and social wellbeing. Research indicates that compassion-training programs have broad health benefits, but how and why compassion-training programs are effective is still relatively unknown. This paper describes the theoretical underpinnings of a specific compassion-training program, CBCT®(Cognitively-Based Compassion Training), and proposes an integrative model that draws on existing health behavior constructs to identify CBCT’s core components and hypothesizes their directionality and interaction. The model includes two primary categories of skill development: (1) intrapersonal skills leading to greater resiliency, and (2) interpersonal skills leading to greater compassion. It is hypothesized that these two pathways are mutually reinforcing and both contribute to greater wellbeing. This model provides a foundation for theory-driven research on the underlying mechanisms in CBCT training. An understanding of CBCT’s mechanisms is a critical step towards optimizing and personalizing the intervention to meet the needs of specific populations.

30 September 2022 in Journal of Clinical Nursing
Verified
Journal Article
Open access
NLNatalie Lambert
Natalie Lambert
SCSurvivor Corps
Survivor Corps
SESarah A. El‐Azab
Sarah A. El‐Azab
NRNathan S. Ramrakhiani
Nathan S. Ramrakhiani
ABAnthony Barisano
Anthony Barisano
MPMelissa D. Pinto
Melissa D. Pinto
Aims and Objectives: To determine the frequency, timing, and duration of post‐acute sequelae of SARS‐CoV‐2 infection (PASC) and their impact on health and function.Background: Post‐acute sequelae of SARS‐CoV‐2 infection is an emerging major public health problem that is poorly understood and has no current treatment or cure. PASC is a new syndrome that has yet to be fully clinically characterised.Design: Descriptive cross‐sectional survey (n = 5163) was conducted from online COVID‐19 survivor support groups who reported symptoms for more than 21 days following SARS‐CoV‐2 infection.Methods: Participants reported background demographics and the date and method of their covid diagnosis, as well as all symptoms experienced since onset of covid in terms of the symptom start date, duration, and Likert scales measuring three symptom‐specific health impacts: pain and discomfort, work impairment, and social impairment. Descriptive statistics and measures of central tendencies were computed for participant demographics and symptom data.Results: Participants reported experiencing a mean of 21 symptoms (range 1–93); fatigue (79.0%), headache (55.3%), shortness of breath (55.3%) and difficulty concentrating (53.6%) were the most common. Symptoms often remitted and relapsed for extended periods of time (duration M = 112 days), longest lasting symptoms included the inability to exercise (M = 106.5 days), fatigue (M = 101.7 days) and difficulty concentrating, associated with memory impairment (M = 101.1 days). Participants reported extreme pressure at the base of the head, syncope, sharp or sudden chest pain, and “brain pressure” among the most distressing and impacting daily life.Conclusions: Post‐acute sequelae of SARS‐CoV‐2 infection can be characterised by a wide range of symptoms, many of which cause moderate‐to‐severe distress and can hinder survivors' overall well‐being.Relevance to Clinical Practice: This study advances our understanding of the symptoms of PASC and their health impacts.

7 February 2022 in The Journal for Nurse Practitioners
Verified
Journal Article
Open access
MPMelissa D. Pinto
Melissa D. Pinto
NLNatalie Lambert
Natalie Lambert
CDCharles A. Downs
Charles A. Downs
HAHeather Abrahim
Heather Abrahim
THThomas D. Hughes
Thomas D. Hughes
RCRana Chakraborty
Rana Chakraborty
Postacute sequelae of SARS-CoV2 (PASC) infection is an emerging global health crisis, variably affecting millions worldwide. PASC has no established treatment. We describe 2 cases of PASC in response to opportune administration of over-the-counter antihistamines, with significant improvement in symptoms and ability to perform activities of daily living. Future studies are warranted to understand the potential role of histamine in the pathogenesis of PASC and explore the clinical benefits of antihistamines in the treatment of PASC.

23 September 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MPMelissa D. Pinto
Melissa D. Pinto
CDCharles A. Downs
Charles A. Downs
YHYong Huang
Yong Huang
SESarah A. El-Azab
Sarah A. El-Azab
NRNathan S. Ramrakhiani
Nathan S. Ramrakhiani
NLNatalie Lambert
Natalie Lambert
Long-haul COVID-19, also called post-acute sequelae of SARS-CoV-2 (PASC), is a new illness caused by SARS-CoV-2 infection and characterized by the persistence of symptoms. The purpose of this cross-sectional study was to identify a distinct and significant temporal pattern of PASC symptoms (symptom type and onset) among a nationwide sample of PASC survivors (n = 5652). The sample was randomly sorted into two independent samples for exploratory (EFA) and confirmatory factor analyses (CFA). Five factors emerged from the EFA: (1) cold and flu-like symptoms, (2) change in smell and/or taste, (3) dyspnea and chest pain, (4) cognitive and visual problems, and (5) cardiac symptoms. The CFA had excellent model fit (x2 = 513.721, df = 207, p < 0.01, TLI = 0.952, CFI = 0.964, RMSEA = 0.024). These findings demonstrate a novel symptom pattern for PASC. These findings can enable nurses in the identification of at-risk patients and facilitate early, systematic symptom management strategies for PASC.

1 June 2015 in Journal of Health and Human Services Administration
Verified
Journal Article
Closed access
RHRonald L. Hickman
Ronald L. Hickman
JCJohn M. Clochesy
John M. Clochesy
MPMelissa D. Pinto
Melissa D. Pinto
CBChristopher Burant
Christopher Burant
GPGrant Pignatiello
Grant Pignatiello
Most Americans will acquire a chronic disease during their lifetime. One of the most prevalent chronic diseases that affect Americans is hypertension (HTN). Despite the known comorbidities and increased mortality rate associated with uncontrolled HTN, most community dwelling adults with HTN do not have sufficient blood pressure control. Therefore, the aim of this article is to report the preliminary efficacy of a serious game for health to enhance blood pressure control among community dwelling adults with HTN. A nonprobability sample of 116 community dwelling adults with HTN participated in this nonblinded, randomized controlled trial. Participants were randomly assigned to: (1) an intervention arm that consisted of four exposures to a serious game for health known as eSMART-HD; or (2) an attentional control arm that compromised of four exposures to screen-based HTN education. The primary outcome measure for this trial was blood pressure reduction over a four month observational period. In this study, baseline characteristics and blood pressure measurements were similar between participants in each study arm. There was no significant between-group difference in blood pressure reduction over time. However, there were significant within-group reductions in systolic and diastolic blood pressures across time among favoring participants exposed to eSMART-HD. This study establishes the preliminary efficacy of eSMART-HD that can be easily administered to community dwelling adults and facilitate clinically significant reductions in systolic and diastolic blood pressures. Future studies should assess the influential components of this promising serious game for health (eSMART-HD) combined with medication management in larger and more diverse samples of community dwelling adults with HTN.